Translate
About
Immunovia Publ Ab (PINK:IMMVF) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 2 2025
Immunovia publishes the Annual Report for 2024
Apr 1 2025
The exercise period for warrants series TO 3 begins today
Mar 27 2025
Immunovia announces determined exercise price for warrants series TO 3
Mar 24 2025
Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test
Mar 21 2025
Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study
Financials
Revenue
$786 K
Market Cap
$16.62 M
EPS
-0.04